What is the significance of a serum creatinine of 1.39 mg/dL and what management steps should be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A serum creatinine of 1.39 mg/dL requires immediate calculation of estimated GFR to determine true kidney function, as this value may represent significant renal impairment despite appearing only mildly elevated.

You must calculate the estimated glomerular filtration rate (eGFR) using the MDRD equation, as serum creatinine alone grossly overestimates kidney function and can mask moderate to severe chronic kidney disease. 1

Why Creatinine Alone Is Inadequate

Serum creatinine of 1.39 mg/dL can represent vastly different levels of kidney function depending on:

  • Age - older patients generate less creatinine from reduced muscle mass
  • Sex - women have lower baseline creatinine production
  • Race - affects creatinine generation rates
  • Body size and muscle mass - lower muscle mass produces less creatinine

A 70-year-old woman with creatinine 1.39 mg/dL may have an eGFR of 35-40 mL/min/1.73m² (Stage 3B CKD), while a 30-year-old muscular man with the same creatinine may have normal kidney function 1, 2.

Calculate eGFR Immediately

Use the simplified MDRD equation:

  • GFR (mL/min/1.73m²) = 186 × [serum creatinine]^-1.154 × [age]^-0.203 × [0.742 if female] × [1.212 if black] 3, 1

Alternative Cockcroft-Gault formula (estimates creatinine clearance):

  • CrCl (mL/min) = [140 - age] × weight (kg) × [0.85 if female] / (72 × serum creatinine) 3, 1

Interpret Based on eGFR Staging

CKD Stage Classification 1, 2:

  • eGFR ≥90: Stage 1 (normal, but requires evidence of kidney damage)
  • eGFR 60-89: Stage 2 (mild reduction)
  • eGFR 30-59: Stage 3 (moderate reduction) - referral threshold
  • eGFR 15-29: Stage 4 (severe reduction) - nephrology consultation required
  • eGFR <15: Stage 5 (kidney failure)

Values below 60 mL/min/1.73m² indicate chronic kidney disease regardless of other findings 2.

Essential Next Steps

1. Screen for Kidney Damage Markers

Obtain spot urine albumin-to-creatinine ratio 1:

  • ≥30 mg/g: Microalbuminuria (early kidney damage)
  • ≥300 mg/g: Macroalbuminuria (established damage)
  • This predicts cardiovascular events and progression to end-stage renal disease

2. Identify Reversible Causes

Stop or adjust immediately 4:

  • NSAIDs - direct nephrotoxicity
  • Diuretics - may cause prerenal azotemia
  • ACE inhibitors/ARBs - can cause up to 20% creatinine increase (acceptable if stable) 1
  • Metformin - if eGFR <60, adjust dose; if <30, discontinue 5
  • Contrast agents - recent exposure suggests contrast-induced AKI

3. Assess for Acute vs. Chronic

Compare to baseline creatinine from previous 3 months 4:

  • Increase ≥0.3 mg/dL within 48 hours: Acute kidney injury (AKI)
  • Increase ≥1.5× baseline within 7 days: AKI
  • Stable elevation >3 months: Chronic kidney disease

4. Risk Stratification for Complications

Cardiovascular Risk: Even "high-normal" creatinine (1.0-1.5 mg/dL) independently predicts cardiovascular events and stroke, with risk increasing progressively 6, 7. This patient requires aggressive cardiovascular risk factor management.

Surgical Risk: Creatinine 1.39 mg/dL may indicate significantly impaired eGFR, which increases perioperative mortality and complications 8. Calculate eGFR before any surgical procedures.

Referral Criteria

Refer to nephrology when 9, 10:

  • eGFR <60 mL/min/1.73m² (Stage 3 or higher CKD)
  • Any progressive increase in creatinine over serial measurements
  • Difficulty managing hypertension or hyperkalemia
  • Proteinuria present (>500 mg/day or albumin-to-creatinine ratio ≥300 mg/g)

Urgent nephrology consultation if 9:

  • eGFR <30 mL/min/1.73m² (Stage 4-5 CKD)
  • Acute rise in creatinine meeting AKI criteria
  • Preparation for renal replacement therapy requires ≥12 months of nephrology follow-up 10

Common Pitfall to Avoid

Do not assume creatinine 1.39 mg/dL represents "mild" kidney disease. Research demonstrates that serum creatinine values still within or near the normal range frequently correspond to moderate or severe renal dysfunction when eGFR is calculated 2, 8. In one cardiac surgery study, 61% of patients with Stage 3+ CKD had creatinine <1.50 mg/dL, and 83% had creatinine below the traditional "abnormal" threshold 8.

Management Algorithm

  1. Calculate eGFR using MDRD equation with age, sex, race
  2. Obtain spot urine albumin-to-creatinine ratio
  3. Review medications - stop nephrotoxins, adjust renally-cleared drugs
  4. Compare to baseline - determine if acute or chronic
  5. If eGFR <60: Refer to nephrology
  6. If eGFR 30-60: Optimize blood pressure (<140/90), consider ACE inhibitor/ARB if proteinuria present 9
  7. If eGFR <30: Urgent nephrology consultation for CKD management and dialysis planning

References

Guideline

meeting the challenges of the new k/doqi guidelines.

American Journal of Kidney Diseases, 2003

Research

Serum creatinine values underestimate surgical risk.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2009

Research

Elevated levels of serum creatinine: recommendations for management and referral.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.